ライフサイエンスコーパス: blood pressure reduction

1 ing of the mechanisms resulting in sustained blood pressure reduction.

2 s expected to reduce it in proportion to the blood pressure reduction.

3 ry prevention of HF is strongly dependent on blood pressure reduction.

4 Recent trials underscore the importance of blood pressure reduction.

5 t by virtue of their effects over and beyond blood pressure reduction.

6 sive treatment, despite little difference in blood pressure reduction.

7 death, predominantly stroke, independent of blood pressure reduction.

8 recognized benefits of glycemic control and blood pressure reduction.

9 ditions have focused on glycemic control and blood pressure reduction.

10 iated with improved prognosis independent of blood pressure reduction.

11 program, particularly for smoking, diet, and blood pressure reduction.

12 s on LV mass independent of the magnitude of blood pressure reduction.

13 and vascular risk factor control, including blood pressure reduction.

14 with additional benefits of weight loss and blood pressure reduction.

15 group medical visits and/or microfinance on blood pressure reduction.

16 ration of significant systolic and diastolic blood pressure reductions.

17 uctions proportional to the magnitude of the blood pressure reductions achieved.

18 s placebo-corrected 24-h systolic ambulatory blood pressure reduction after 4 weeks and analysis was

19 We report marked blood pressure reduction after RDN in a patient with res

20 Blood pressure reduction alone provided no benefits; blo

21 essure reduction alone provided no benefits; blood pressure reduction alongside blockade of the endot

22 mm Hg (SD, 2.5 mm Hg), which was similar to blood pressure reduction among participants with suppres

23 en the A allele of beta2-AR G46A and greater blood pressure reduction and blunted aldosterone and PRA

24 urgent treatment of mass effect, aggressive blood pressure reduction and correction of contributing

25 f the SPS3 trial, we aimed to assess whether blood pressure reduction and dual antiplatelet treatment

26 isease in sub-Saharan Africa should focus on blood pressure reduction and individuals with a low CD4+

27 ressure-lowering therapy is the magnitude of blood pressure reduction and perhaps the speed at which

28 or the amlodipine group, correlation between blood pressure reduction and progression was r = 0.19, P

29 ous and rare, produce clinically significant blood pressure reduction and protect from development of

30 ute conduction inhomogeneity, independent of blood pressure reduction and renal function.

31 Blood pressure reduction and renin-angiotensin-aldostero

32 Blood pressure reductions and numbers of events were sma

33 he ACE inhibitor dose, the ARB and its dose, blood pressure reduction, and patient populations-to pre

34 causes regression of ECG-LVH independent of blood pressure reduction, and these changes are associat

35 tus suggested that despite achieving similar blood pressure reductions, angiotensin-converting enzyme

36 despite strong evidence that the benefits of blood pressure reduction are observed in patients across

37 ions in input parameters except for systolic blood pressure reduction, baseline systolic blood pressu

38 The difference in blood pressure reduction between the two groups was not

39 no difference in 24-hour and office systolic blood pressure reduction between trials with and without

40 Systolic blood pressure reduction by 5 mm Hg reduced the risk of

41 d reflex in SH rats was not reduced by acute blood pressure reduction by captopril.

42 Blood pressure reduction by consumption of cocoa product

43 ovided clinically meaningful improvements in blood pressure reduction compared with dual combinations

44 Effectiveness was based on in-trial blood pressure reductions converted to cardiovascular di

45 In this trial, prehospital blood-pressure reduction did not improve functional outc

46 FE, and ALLHAT underscores the importance of blood pressure reduction for patients with coronary arte

47 ults might support the use of more intensive blood pressure reduction for secondary prevention in pat

48 Although intensive blood pressure reduction has cardiovascular benefits, th

49 nostic significance of dIVH in the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage T

50 f the pilot and main phases of the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage T

51 tithrombotic-associated ICH in the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage T

52 cquired from the main phase of the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage T

53 t-data pooled analysis of the four Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage T

54 emonstrated that intermedin treatment led to blood pressure reduction in both normal and spontaneousl

55 An ad libitum NND produces weight loss and blood pressure reduction in centrally obese individuals.

56 by short-term dual antiplatelet treatment or blood pressure reduction in fairly young patients with r

57 Effects of blood pressure reduction in persons with grade 1 hyperte

58 perlipidemic men, with significant diastolic blood pressure reductions in the HYL group only.

59 Multivariate analyses implicate blood pressure reductions in the setting of an active va

60 Ventilatory support, blood-pressure reduction, intracranial-pressure monitori

61 Surgical sympathectomy for blood pressure reduction is an old but extremely efficac

62 The degree to which more intensive blood pressure reduction is better than less intensive f

63 actions of adults with stage I hypertension; blood pressure reduction is enhanced to a similar degree

64 I -24.4 to -21.9; p<0.0001) and in diastolic blood pressure reduction, it was -9.9 mm Hg (-10.6 to -9

65 FrEF, patients with HFpEF experience greater blood pressure reduction, less enhancement in cardiac ou

66 Excessive blood pressure reduction may contribute to poor outcome

67 s in hypertension have reported that similar blood pressure reductions may not necessarily translate

68 This effect, which was independent of blood pressure reduction, may account for the improved c

69 ty plays a key role in promoting the greater blood pressure reduction observed with evening training.

70 Most blood pressure reduction occurred during the first 3 wee

71 In a mouse model of high blood pressure, reduction of nuclear pore numbers improv

72 association between childhood and adulthood blood pressure; reduction of childhood blood pressure; a

73 We did a meta-analysis of blood pressure reductions on relative risk (RR) of major

74 ome large observational cohorts suggest that blood pressure reduction, particularly by angiotensin-co

75 tment LV mass, body weight, the magnitude of blood pressure reduction, race, and age may modify the r

76 hieve their effect, it remains the case that blood pressure reduction remains more important than the

77 Beyond blood pressure reduction, statin therapy is undoubtedly

78 ne achieved a greater systolic and diastolic blood pressure reduction than fosinopril (10 mm Hg versu

79 The blood pressure reduction that would result from a substa

80 c targeting of aldosterone excess as well as blood pressure reduction to minimize cardiac morbidity i

81 f hypertensive emergencies, the intensity of blood pressure reduction to the target pressure differs

82 as based on our collaborative framework, the Blood Pressure Reduction Union-Landmark Evidence, and a

83 produced a clinically meaningful and lasting blood pressure reduction up to 36 months of follow-up, i

84 The cornerstone of treatment remains blood pressure reduction, using agents with both antihyp

85 At 36 months, the ambulatory systolic blood pressure reduction was -18.7 mm Hg (SD 12.4) for t

86 months, the net group difference in systolic blood pressure reduction was -23.1 mm Hg (95% CI -24.4 t

87 verall, the mean magnitude of early systolic blood pressure reduction was 29 mm Hg (SD 22), and subse

88 The average blood pressure reduction was about 3.6/2.4 mm Hg.

89 This trial did not examine whether the blood pressure reduction was due to protein or isoflavon

90 Blood pressure reduction was greater in adolescents with

91 e a higher rate of worsening renal function, blood pressure reduction was not associated with worseni

92 Similarly, the blood pressure reduction was not found to be significant

93 Blood pressure reduction was not significantly different

94 The net changes in systolic and diastolic blood pressure reductions were -7.88 mm Hg (CI, -4.66 to

95 Blood pressure reduction with once-daily diltiazem decre

96 Similar blood pressure reduction with once-daily nifedipine did

97 led promising results for safe and sustained blood pressure reduction with percutaneous renal sympath

98 The greater blood pressure reductions with SR may be mediated in par

99 In a general population, this blood pressure reduction would substantially reduce the